Literature DB >> 1624567

Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection.

O Meurman1, M Waris, K Hedman.   

Abstract

The titer and avidity of respiratory syncytial virus-specific antibodies were measured in 196 serum specimens from 93 children with an acute, laboratory-confirmed respiratory syncytial virus infection. An enzyme immunoassay method based on the ability of urea to dissociate the bound antibodies with low avidity from the antigen was used. Three patterns of immune responses were observed. Children less than 6 months of age usually had low titers of antibodies with high avidity in their acute-phase serum samples. These antibodies were concluded to be of maternal origin, since their reaction pattern was similar to that of healthy adults. During the next few weeks, a slight increase in titers with a concurrent decrease in antibody avidity was observed. All children 6 to 24 months of age had low-avidity antibodies in their acute-phase serum samples, which matured to high avidity during the follow-up. On the contrary, about half of the children greater than 24 months of age had high-avidity antibodies already in the acute-phase serum samples. We conclude that the former children were experiencing primary infections with respiratory syncytial virus and the latter were experiencing reinfections. All adults with remote immunity had antibodies with high avidity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624567      PMCID: PMC265314          DOI: 10.1128/jcm.30.6.1479-1484.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Antibody avidity following varicella-zoster virus infections.

Authors:  H O Kangro; S Manzoor; D R Harper
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

2.  Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children.

Authors:  L J Anderson; R A Parker; R L Strikas
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

3.  Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.

Authors:  P M Muelenaer; F W Henderson; V G Hemming; E E Walsh; L J Anderson; G A Prince; B R Murphy
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

4.  Cellular and humoral immunity in recurrent respiratory syncytial virus infections.

Authors:  G W Fernald; J R Almond; F W Henderson
Journal:  Pediatr Res       Date:  1983-09       Impact factor: 3.756

Review 5.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

6.  Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.

Authors:  R Vainionpää; O Meurman; H Sarkkinen
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

8.  An ELISA for the estimation of high-avidity and total specific IgG and IgM antibodies to rubella virus.

Authors:  O P Lehtonen; O H Meurman
Journal:  J Virol Methods       Date:  1982-09       Impact factor: 2.014

9.  Diagnosis of respiratory syncytial virus infection in children: comparison of viral antigen detection and serology.

Authors:  O Meurman; H Sarkkinen; O Ruuskanen; P Hänninen; P Halonen
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay.

Authors:  O Meurman; O Ruuskanen; H Sarkkinen; P Hänninen; P Halonen
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

View more
  9 in total

1.  Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Authors:  Vanda Akico Ueda Fick de Souza; Silvana Fernandes; Evaldo Stanislau Araújo; Adriana Fumie Tateno; Olímpia M N P F Oliveira; Renato Reis Oliveira; Cláudio Sérgio Pannuti
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.

Authors:  J Forster; O Maier; J Löbbert; K Kaufmehl; H J Streckert; H Werchau
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

Review 5.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

6.  Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.

Authors:  Nao Jounai; Megumi Yoshioka; Miyuki Tozuka; Kazue Inoue; Tatsuya Oka; Kazuki Miyaji; Katsuyasu Ishida; Naoki Kawai; Hideyuki Ikematsu; Chiaki Kawakami; Hiroyuki Shimizu; Masaaki Mori; Ken J Ishii; Fumihiko Takeshita
Journal:  EBioMedicine       Date:  2017-01-16       Impact factor: 8.143

7.  Serological Array-in-Well Multiplex Assay Reveals a High Rate of Respiratory Virus Infections and Reinfections in Young Children.

Authors:  Anna Kazakova; Laura Kakkola; Henna Päkkilä; Tamara Teros-Jaakkola; Tero Soukka; Ville Peltola; Matti Waris; Ilkka Julkunen
Journal:  mSphere       Date:  2019-09-11       Impact factor: 4.389

8.  Advances in the diagnosis of respiratory virus infections.

Authors:  P Halonen; J Herholzer; T Ziegler
Journal:  Clin Diagn Virol       Date:  1996-05

9.  Prospective clinical and serological follow-up in early childhood reveals a high rate of subclinical RSV infection and a relatively high reinfection rate within the first 3 years of life.

Authors:  A Kutsaya; T Teros-Jaakkola; L Kakkola; L Toivonen; V Peltola; M Waris; I Julkunen
Journal:  Epidemiol Infect       Date:  2016-01-06       Impact factor: 4.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.